Vitamin D and Omega-3 for Post-Stroke Outcomes (VITAL Ancillary)

Randomised, double-blind trial of vitamin d and omega-3-acid triglycerides in stroke (4 arms), sponsored by Brigham and Women's Hospital. Primary endpoints: Number of Participants With Poor Stroke Outcome at Hospital Discharge as Measured by the Modified Rankin Scale (mR 3-6) at 1 day, Number of Participants With at Least One Functional Limitation After Stroke According to the Scale Adapted From Nagi at 1 year and 3 more. Started Aug 2016; status: completed.